Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$504K Sell
4,220
-780
-16% -$102K 0.47% 49
2025
Q4
$681K Hold
5,000
0.64% 34
2025
Q3
$738K Hold
5,000
0.55% 47
2025
Q2
$647K Hold
5,000
0.38% 81
2025
Q1
$597K Buy
+5,000
New +$620K 0.42% 69

Other funds holding XYL

Corient IA's XYL Position: Q1 2026 in Review

Corient IA reduced its Xylem (XYL) stake by 16% in Q1 2026, selling an estimated $102K and leaving 4,220 shares worth $504K. The position accounts for 0.47% of the portfolio, ranked #49.

Corient IA first reported a position in XYL in Q1 2025 and has held it in 5 quarters since. The position peaked at $738K in Q3 2025. 1,107 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • Corient IA held 4,220 shares of Xylem worth $504K as of Q1 2026.
  • Corient IA sold 780 Xylem shares in Q1 2026, an estimated $102K.
  • Xylem made up 0.47% of Corient IA's portfolio in Q1 2026, its #49 holding.
  • Corient IA first reported a position in Xylem in Q1 2025 and has held it in 5 quarters since.
  • Corient IA's Xylem position peaked at $738K in Q3 2025.
  • 1,107 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on Corient IA's 13F filing for Q1 2026, filed 14 May 2026.